NCT00193011View on ClinicalTrials.gov

Weekly Docetaxel and CMF in the Adjuvant Treatment of Elderly Women With High-Risk Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Breast Cancer
Interventions
DRUG

Docetaxel

Docetaxel

DRUG

Cyclophosphamide

Cyclophosphamide

DRUG

Methotrexate

Methotrexate

DRUG

5-Fluorouracil

5-Fluorouracil

Sponsors

Collaborators (1)

Aventis Pharmaceuticals
All Listed Sponsors
collaborator

Aventis Pharmaceuticals

INDUSTRY

lead

SCRI Development Innovations, LLC

OTHER